Category: MassDevice.com Earnings RoundupSyndicate content

Baxter blows away Wall Street as renal sales surge in Q1

April 17, 2014 by Arezu Sarvestani

Baxter International's medical products division gets a major boost in the company's 1st quarter, pushing adjusted per-share earnings 9¢ above expectations.

Baxter blows away Wall Street with dialysis sales surge in Q1

Illinois healthcare titan Baxter (NYSE:BAX) isn't getting much Wall Street love today after posting Q1 adjusted per-share earnings that blew away expectations.

GE Healthcare's Q1 sales, profits slide

April 17, 2014 by Brad Perriello

Sales and profits were down during the 1st quarter for GE Healthcare, which cited "market volatility" for the declines.

keys: ge healthcare, general electric, earnings

GE Healthcare's Q1 sales, profits slide

GE Healthcare (NYSE:GE) saw its sales and profits decline by single digits during the 1st quarter due to "market volatility.

Urologix completes layoffs, announces preliminary results

April 16, 2014 by Arezu Sarvestani

Minnesota medical device maker Urologix completes the previously announced restructuring of its sales team as the company prepares to release its 3rd quarter earnings.

Urologix completes layoffs, announces preliminary results

Abbott's earnings take a beating in Q1

April 16, 2014 by Arezu Sarvestani

Abbott Labs' earnings sink more than 30% in its 1st quarter of 2014 as special charges eat up its bottom line.

Abbott's earnings take a beating in Q1

Illinois-based Abbott (NYSE:ABT) managed to beat analysts' expectations for its 1st quarter, even as sales waned and special charges eroded its bottom line.

St. Jude Medical beats The Street, loses points anyway

April 16, 2014 by Arezu Sarvestani

St. Jude Medical meets Wall Street's expectations for its 1st quarter of 2014 with moderate sales growth across its product lines, but shares take a downward turn in morning trading.

St. Jude Medical meets The Street, loses points anyway

Minnesota medtech titan St. Jude Medical (NYSE:STJ) lost a few points on Wall Street today after posting 1st quarter earnings a penny above analysts' consensus estimate.

Johnson & Johnson's Q1 sales, earnings beat forecasts

April 15, 2014 by Brad Perriello

Johnson & Johnson's 1st-quarter sales and earnings top expectations on another strong pharma contribution; flat sales for medical devices driven by diabetes business decline.

Johnson & Johnson's Q1 sales, earnings beat forecasts

Johnson & Johnson (NYSE:JNJ) topped expectations with its 1st-quarter results and raised its outlook for the rest of the year, sending share prices up this morning.

AngioDynamics swings to Q3 black, beats The Street

April 14, 2014 by Brad Perriello

AngioDynamics reports a profitable fiscal 3rd quarter and nearly doubles Wall Street's earnings forecast, but shares slide anyway.

AngioDynamics swings to Q3 black, beats The Street

AngioDynamics (NSDQ:ANGO) put some black ink in the ledger during its fiscal 3rd quarter and handily topped Wall Street's earnings forecast, but investors have remained unmoved, sending ANGO shares down 12% since its April 9 earnings release.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp